The authors found concurrent growth in pharmacy benefit manager market concentration and worsening of patient access measures across states from 2016 to 2025.
|Articles|February 1, 1996
The American Journal of Managed Care
- February 1996
- Volume 2
- Issue 2
Quantitative and Cost Evaluation of Three Antiglaucoma Beta-Blocker Agents: Timoptic-XE7 versus Two Generic Levobunolol Products
Advertisement
Articles in this issue
almost 31 years ago
Adapting Pharmacy Services to the Needs of Managed Carealmost 31 years ago
Advanced Practice Nurses and Success of Organized Delivery Systemsalmost 31 years ago
Ethical Issues in Managed Carealmost 31 years ago
The Economics of Compliance in Managed Healthcare SettingsAdvertisement
Related to this article
Health care special purpose acquisition companies in 2020-2021 represented a temporary market inefficiency that enabled weaker companies to bypass traditional due diligence and ultimately led to failures.
Machine learning prediction of procalcitonin positivity using inexpensive routine laboratory tests may reduce procalcitonin test volume and support diagnostic stewardship.
After Pennsylvania began rewarding Medicaid managed care plans for increasing well-child visits among Black infants, rates did not change significantly overall but varied by region.
Advertisement
Advertisement
Trending on AJMC
1
Payers, Eosinophil Thresholds Shape Who Gets a COPD Biologic
2
Study Finds Possible Deep Endometriosis in 7% of Postmenopausal Women
3
Early-Onset Cancers Often Found Late as Screening Gaps Persist
4
AHIP's Jeanette Thornton on Prior Authorization Reform, Midterms
5